-Reuters
Petra Acquisition M&A Partner Revelation Biosciences Receives Approval To Begin Phase 1b Clinical Study Of REVTx-99 As An Experimental Treatment For Allergic Rhinitis And Chronic Nasal Congestion
Revelation Biosciences Inc. (Revelation), a clinical-stage life sciences company that is focused on the development of immunologic‑based therapies for the prevention and treatment of disease, announced today it has been